Evidence map›Paper›PMID 34434552›Full record

ArticleTherapeutic advances in infectious disease

Knowledge assessment of anti-snake venom among healthcare practitioners in northern Nigeria.

Auwal A Bala, Abubakar I Jatau, Ismaeel Yunusa, Mustapha Mohammed, Al-Kassim H Mohammed, Abubakar M Isa, Abubakar S Wada, Kabiru A Gulma, Inuwa Bello, Sani Malami and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Toxins · 2025
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 5 countries.

Auwal A BalaDepartment of Pharmacology, College of Medicine and Health Sciences, Federal University Dutse, Dutse, Jigawa 7200234, Nigeria, Department of Pharmacology and Therapeutics, Bayero University, Kano, Nigeria.ORCID https://orcid.org/0000-0003-0402-9639
Abubakar I JatauSchool of Pharmacy and Pharmacology, University of Tasmania, Tasmania, Australia.
Ismaeel YunusaUniversity of South Carolina College of Pharmacy, Columbia, South Carolina, USA.
Mustapha MohammedSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Pulau Pinang, Malaysia, Department of Clinical Pharmacy and Pharmacy Practice, Ahmadu Bello University, Zaria, Kaduna, Nigeria.
Al-Kassim H MohammedFaculty of Pharmaceutical Sciences, Bayero University, Kano, Nigeria.
Abubakar M IsaMalaria Consortium, Jigawa State Office, Dutse, Nigeria.
Abubakar S WadaDepartment of Pharmacology and Therapeutics, Bayero University, Kano, Nigeria.
Kabiru A GulmaSchool of Global Health and Bioethics, Euclid University, Banjul, Gambia.
Inuwa BelloJigawa State Hospital Services, Dutse, Nigeria.
Sani MalamiDepartment of Pharmacology and Therapeutics, Bayero University, Kano, Nigeria.
Godpower C MichaelDepartment of Family Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria.
Basheer Az ChediDepartment of Pharmacology and Therapeutics, Bayero University, Kano, Nigeria, Venom-Antivenom Research Project (VASP) and Nigeria-Snakebite Research and Intervention Centre (N-SRIC), Kano, Nigeria.
Bayero University Kano · NGAhmadu Bello University · NGAminu Kano Teaching Hospital · NGEuclid University · GMFederal University DutseUniversity of South Carolina · USUniversity of Tasmania · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAnti-snake venom (ASV) is the standard therapy for the management of snakebite envenoming (SBE). Therefore, the knowledge of ASV among healthcare practitioners (HCPs) is essential for achieving optimal clinical outcomes in snakebite management. This study aimed to assess knowledge of ASV among the HCPs in northern Nigeria.

methodsWe conducted a cross-sectional study involving eligible HCPs from different healthcare settings in northern Nigeria. The participants were recruited into the study using a combination of online (via Google Form) and face-to-face paper-based survey methods. The ASV knowledge of the respondents was measured using a validated anti-snake venom knowledge assessment tool (AKAT). Inadequate overall knowledge of ASV was defined as scores of 0-69.9%, and 70-100% were considered adequate overall knowledge scores. The predictors of ASV knowledge were determined using multiple logistic regression.

resultsThree hundred and thirty-one (331) eligible HCPs were included in the study analysis (310 from online and 21 from paper-based survey). Overall, an estimated 12.7% of the participants had adequate knowledge of ASV. Adequate ASV knowledge was higher among physicians compared with other HCPs (21.7%; χ

conclusionThe knowledge of ASV among healthcare practitioners in northern Nigeria is grossly inadequate. Experience with administering or dispensing ASV predicts ASV knowledge. Therefore, appropriate interventions are needed to improve ASV knowledge, particularly among the HCPs, for optimal healthcare outcomes.

Indexed as

antisnake venomassessmenthealthcareknowledgeNigeriapractitionerssurvey

Identifiers

PMID34434552
PMCPMC8381460
OpenAlexW3195878537

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.